Format

Send to

Choose Destination
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1188-1197. doi: 10.1210/jc.2017-02381.

A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls With Turner Syndrome.

Author information

1
Department of Pediatrics, Second Medical Faculty, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
2
Department of Pediatrics, University Hospital Cologne and Cologne University, Cologne, Germany.
3
Stratec Medizintechnik GmbH, Pforzheim, Germany.
4
Department of Probability and Mathematical Statistics, Faculty of Mathematics and Physics, Charles University in Prague, Prague, Czech Republic.

Abstract

Context:

Patients with Turner syndrome (TS) are at risk for osteoporotic fractures.

Objective:

The aims of this study were to assess the incidence of clinically important fractures in girls with TS and prospectively describe the development of volumetric bone mineral density (BMD).

Design:

Peripheral quantitative computerized tomography (pQCT) of the radius every other year over the 6 years of observation.

Setting:

Government-funded university referral center.

Participants:

Thirty-two girls with TS, aged 6 to 16 years, were included in the analyses. Fracture incidence was compared with the data in the general population. Bone density and strength were compared with data from 185 healthy girls.

Outcomes:

The main clinical outcome was the fracture occurrence. The secondary outcomes were the changes in Z-scores of the bone parameters.

Results:

Three girls with TS sustained four fractures during 6 years of observation. The fracture rate in TS was not substantially higher than the downward-biased fracture-rate estimate from age-matched, healthy controls (P = 0.48). Whereas the trabecular BMD Z-score decreased with age (β estimate -0.21 ± 0.04, P < 0.001), total bone cross-sectional area correspondingly increased (+0.16 ± 0.04, P < 0.001), which led to normal bone strength. A positive history of incident fractures was not significantly associated with any of the pQCT-derived bone parameters.

Conclusions:

Current pediatric TS patients that are treated with growth hormone and estrogens are not at risk for osteoporotic fractures. Low BMD in TS may be counterweighted by enlarged bone radius, which leads to normal bone strength at the appendicular skeleton.

PMID:
29300907
DOI:
10.1210/jc.2017-02381
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center